Medpace Holdings General Counsel Stephen P. Ewald Sells $859K in Common Stock
Medpace Holdings, Inc.
Subscribe to track MEDP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
[FORM 4 INSIDER TRANSACTION]
Issuer: Medpace Holdings, Inc. ($MEDP)
Insider: EWALD STEPHEN P
Title: General Counsel & Corp. Secy.
Type: Sale (Code: S)
Shares: 1,245 @ $690.00
Total Value: $859,050.00
Remaining Ownership: 19,098 shares
Significance: Medium
Comprehensive Analysis
Executive Summary
On October 29, 2026, Stephen P. Ewald, General Counsel and Corporate Secretary of Medpace Holdings, Inc. ($MEDP), executed an open-market sale of 1,245 shares of common stock at a price of $690.00 per share, generating gross proceeds of $859,050.00.
Transaction Details
- Security: Common Stock
- Transaction Type: Open Market Sale (Code: S)
- Shares Sold: 1,245 shares
- Execution Price: $690.00 per share
- Total Transaction Value: $859,050.00
- Post-Transaction Holdings: 19,098 shares held directly
- Trading Plan / Mechanism: The filing notes that the transaction was executed pursuant to a limit order placed during an open trading window and was not conducted under a Rule 10b5-1 trading plan (
aff10b5Onemarked as 0).
Ownership Impact & Context
Prior to this transaction, Mr. Ewald held 20,343 shares of Medpace common stock. This sale represents approximately 6.12% of his total direct equity holdings, leaving him with 19,098 direct shares valued at over $13.1 million at the execution price. Given the moderate percentage of holdings liquidated and the transaction size under $1 million, the transaction is assessed as having Medium trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
